S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week

Ovid Therapeutics (OVID) News Today

$3.23
+0.02 (+0.62%)
(As of 04/19/2024 ET)
SourceHeadline
finance.yahoo.com logoWe Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
finance.yahoo.com - April 18 at 9:24 AM
marketbeat.com logoOvid Therapeutics Inc. (NASDAQ:OVID) Short Interest Down 23.7% in March
marketbeat.com - April 13 at 4:57 PM
msn.com logoOvid Therapeutics gains on bullish view at Wedbush
msn.com - April 5 at 6:25 PM
marketbeat.com logoOvid Therapeutics (NASDAQ:OVID) Coverage Initiated at Wedbush
marketbeat.com - April 5 at 8:21 AM
globenewswire.com logoOvid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - April 4 at 8:00 AM
msn.com logoMarinus Pharmaceuticals Stands Firm in Patent Dispute Over Key Epilepsy Treatment
msn.com - April 2 at 8:07 AM
bizjournals.com logoMarinus Pharmaceuticals' patent battle with New York firm over seizure therapy takes new twist
bizjournals.com - March 29 at 5:22 PM
investing.com logoOvid therapeutics CEO acquires $50k in company stock
investing.com - March 22 at 7:33 PM
finance.yahoo.com logoOvid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying
finance.yahoo.com - March 22 at 8:51 AM
insidertrades.com logoOvid Therapeutics Inc. (NASDAQ:OVID) CEO Jeremy M. Levin Acquires 18,248 Shares
insidertrades.com - March 21 at 10:32 AM
marketbeat.com logoJeremy M. Levin Purchases 18,248 Shares of Ovid Therapeutics Inc. (NASDAQ:OVID) Stock
marketbeat.com - March 20 at 7:54 PM
insidermonkey.com logo5 Oversold Biotech Stocks To Buy Right Now
insidermonkey.com - March 17 at 7:29 PM
markets.businessinsider.com logoOvid Therapeutics: Strong Buy Rating on Robust Pipeline and Strategic Partnerships
markets.businessinsider.com - March 13 at 7:49 AM
news.yahoo.com logoOvid gas station, state and local officials dealing with contaminated fuel problem
news.yahoo.com - March 13 at 1:54 AM
msn.com logoOvid gas station shut down after discovery of water inside pumps
msn.com - March 13 at 1:54 AM
markets.businessinsider.com logoTD Cowen Sticks to Its Buy Rating for Ovid Therapeutics (OVID)
markets.businessinsider.com - March 11 at 8:32 AM
finance.yahoo.com logoOVID Oct 2024 7.500 call
finance.yahoo.com - March 9 at 7:17 AM
benzinga.com logoRecap: Ovid Therapeutics Q4 Earnings
benzinga.com - March 8 at 10:42 AM
globenewswire.com logoOvid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
globenewswire.com - March 8 at 8:00 AM
investing.com logoOvid Therapeutics Inc (OVID)
investing.com - March 7 at 11:47 PM
globenewswire.com logoOvid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
globenewswire.com - February 28 at 8:00 AM
news.yahoo.com logoOvid-Elsie girls win third straight conference title
news.yahoo.com - February 22 at 9:16 AM
marketbeat.com logoOvid Therapeutics Inc. (NASDAQ:OVID) Short Interest Update
marketbeat.com - February 17 at 8:11 AM
finance.yahoo.com logoOVID Mar 2024 5.000 call
finance.yahoo.com - February 17 at 1:37 AM
finance.yahoo.com logoOVID Apr 2024 5.000 call
finance.yahoo.com - February 17 at 1:37 AM
msn.com logoTaysha transfers rights to 3 programs, extends cash runway into 2026
msn.com - February 15 at 6:49 PM
finance.yahoo.com logoOvid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
finance.yahoo.com - February 6 at 8:46 AM
msn.com logoCirculatory cholesterol levels are inversely linked to mortality of patients with sepsis and critical illness
msn.com - February 1 at 1:24 PM
finance.yahoo.com logoOwning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),
finance.yahoo.com - January 18 at 8:28 AM
marketbeat.com logoOvid Therapeutics Inc. (NASDAQ:OVID) Sees Large Increase in Short Interest
marketbeat.com - January 14 at 5:06 PM
markets.businessinsider.com logoBTIG Keeps Their Buy Rating on Ovid Therapeutics (OVID)
markets.businessinsider.com - January 3 at 9:45 AM
finance.yahoo.com logoEnavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors
finance.yahoo.com - January 2 at 8:45 AM
benzinga.com logoOvid Therapeutics Stock (NASDAQ:OVID), Analyst Ratings, Price Targets, Predictions
benzinga.com - December 22 at 2:13 PM
benzinga.com logoOvid Therapeutics Stock (NASDAQ:OVID) Dividends: History, Yield and Dates
benzinga.com - December 21 at 6:56 PM
msn.com logoBTIG Initiates Coverage of Ovid Therapeutics (OVID) with Buy Recommendation
msn.com - December 21 at 6:56 PM
marketbeat.com logoOvid Therapeutics (NASDAQ:OVID) Earns Buy Rating from Analysts at BTIG Research
marketbeat.com - December 21 at 7:16 AM
finance.yahoo.com logoS&W Seed Company Appoints Jeffrey Rona to Its Board of Directors
finance.yahoo.com - December 19 at 9:35 AM
finance.yahoo.com logoOvid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
finance.yahoo.com - December 1 at 12:23 PM
marketbeat.com logo
marketbeat.com - November 30 at 9:31 AM
morningstar.com logoOvid Therapeutics Inc OVID
morningstar.com - November 16 at 12:04 AM
markets.businessinsider.com logoPromising Developments and Strategic Partnerships Bolster Buy Rating for Astria Therapeutics
markets.businessinsider.com - November 14 at 3:11 PM
finance.yahoo.com logoOvid Therapeutics (OVID) Upgraded to Buy: Here's Why
finance.yahoo.com - November 9 at 5:44 PM
markets.businessinsider.com logoRobust Financial Health and Promising Drug Development Propel Buy Rating for Ovid Therapeutics
markets.businessinsider.com - November 7 at 7:15 AM
finance.yahoo.com logoOvid Therapeutics Inc (OVID) Reports Q3 2023 Financial Results
finance.yahoo.com - November 5 at 8:13 PM
benzinga.com logoOvid Therapeutics Stock (NASDAQ:OVID) Earnings Dates and Earning Calls
benzinga.com - November 5 at 3:12 PM
msn.com logoOvid Therapeutics files for $250M mixed shelf
msn.com - November 3 at 7:02 PM
finanznachrichten.de logoOvid Therapeutics Inc.: Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
finanznachrichten.de - November 3 at 1:55 PM
msn.com logoOvid Therapeutics reports Q3 results
msn.com - November 3 at 1:55 PM
finance.yahoo.com logoOvid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
finance.yahoo.com - November 3 at 1:55 PM
msn.com logoOvid Therapeutics (OVID) Price Target Increased by 10.29% to 6.38
msn.com - November 1 at 5:57 PM
Get Ovid Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for OVID and its competitors with MarketBeat's FREE daily newsletter.

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

OVID Media Mentions By Week

OVID Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OVID
News Sentiment

1.07

0.51

Average
Medical
News Sentiment

OVID News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OVID Articles
This Week

1

1

OVID Articles
Average Week

Get Ovid Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for OVID and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:OVID) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners